Cite

HARVARD Citation

    Saki, N. et al. (2022). Topical gabapentin 10% in the treatment of epidermolysis bullosa pruritus: A pilot, double‐blind, split‐site, randomized controlled trial. Dermatologic therapy. 35 (10), p. n/a. [Online]. 
  
Back to record